Search results for "bacterial"

showing 10 items of 3246 documents

Treatment of human brucellosis with rifampin plus minocycline

2003

In order to evaluate the efficacy and tolerability of a high intravenous dose of rifampin plus oral minocycline (administered daily for 3 weeks) for the treatment of acute brucellosis, we retrospectively reviewed the outcome of 239 consecutive patients (135 adults and 104 children) diagnosed and treated over a 17-year period in Italy. The combination used resulted in 100% response and a relapse rate lower than 2%. Fifty-two (30 adults and 22 children) (29.8%) complained of mild adverse effects including an increase in aspartate aminotransferase (>250 IU) observed in 12 cases and considered related to rifampin and in 11 cases a reversible hyperpigmentation of the tongue attributed to minocyc…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentMinocyclineRisk AssessmentDrug Administration SchedulePharmacotherapyRecurrenceInternal medicinemedicineHumansPharmacology (medical)ChildInfusions IntravenousAdverse effectAgedRetrospective StudiesAntibacterial agentAged 80 and overPharmacologyChemotherapyDose-Response Relationship Drugbusiness.industryRetrospective cohort studyMinocyclineMiddle AgedBrucellaSurgeryTreatment OutcomeInfectious DiseasesItalyOncologyTolerabilityChild PreschoolbrucellosisDrug Therapy CombinationFemaleRifampinbusinessRifampicinFollow-Up Studiesmedicine.drug
researchProduct

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

2007

Summary Background Invasive candidosis is increasingly prevalent in seriously ill patients. Our aim was to compare micafungin with liposomal amphotericin B for the treatment of adult patients with candidaemia or invasive candidosis. Methods We did a double-blind, randomised, multinational non-inferiority study to compare micafungin (100 mg/day) with liposomal amphotericin B (3 mg/kg per day) as first-line treatment of candidaemia and invasive candidosis. The primary endpoint was treatment success, defined as both a clinical and a mycological response at the end of treatment. Primary analyses were done on a per-protocol basis. This trial is registered with ClinicalTrials.gov, number NCT00106…

AdultMalemedicine.medical_specialtyAntifungal AgentsAdolescentLipoproteinsAmphotericin B/ therapeutic useMicrobial Sensitivity TestsLipoproteins/ therapeutic usePeptides CyclicEchinocandinsLipopeptideschemistry.chemical_compoundDouble-Blind MethodAmphotericin BInternal medicineAmphotericin BPeptides Cyclic/ therapeutic usemedicineHumansAdverse effectMycosisFungemiaCandidiasis/complications/ drug therapy/microbiologyAPACHEAgedddc:616Aged 80 and overVoriconazolebusiness.industryAntifungal Agents/ therapeutic useCandidiasisMicafunginGeneral MedicineMiddle Agedbacterial infections and mycosesmedicine.diseaseApacheSurgeryTreatment OutcomechemistryMicafunginFemaleCaspofunginbusinessFluconazolemedicine.drugThe Lancet
researchProduct

Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis

1992

Infective endocarditis is associated with significant morbidity and mortality, with valvular destruction and congestive heart failure being more common in patients with echocardiographically discernible vegetations. The transoesophageal approach affords consistently high quality images with excellent structural resolution. Two-hundred and eighty-one patients with clinically suspected infective endocarditis were studied, to evaluate the prognostic value of ascertaining the site of vegetations. Among them were 118 patients with vegetations attached to the aortic or mitral valve. These patients were followed for a mean period of 14 months. Mitral valve vegetations were associated with a signif…

AdultMalemedicine.medical_specialtyAortic Valve InsufficiencyPostoperative ComplicationsSepsisStreptococcal InfectionsMitral valveInternal medicinemedicineHumansEndocarditisProspective StudiesHeart valveProspective cohort studyAbscessbusiness.industryMitral Valve InsufficiencyEndocarditis BacterialIntracranial Embolism and ThrombosisMiddle AgedStaphylococcal InfectionsPrognosismedicine.diseaseAbscessSurgerymedicine.anatomical_structureEmbolismEchocardiographyAortic ValveHeart Valve ProsthesisHeart failureInfective endocarditisCardiologyMitral ValveFemaleCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size.

1991

The diagnostic value of transesophageal echocardiography in monitoring the clinical course has been evaluated in 83 patients with echocardiographic evidence of infective endocarditis. A total of 103 vegetations attached to the aortic or mitral valves were detected by use of the transesophageal approach. The patients were monitored for a mean of 74 weeks and underwent a minimum of two consecutive transesophageal echocardiographic examinations. Group A included patients with increasing or remaining constant size of vegetation (8.2 +/- 1.5 to 11.2 mm, p less than 0.05) during 4 to 8 weeks of antimicrobial therapy, whereas group B was formed by patients with decreasing vegetation size (8.3 +/- …

AdultMalemedicine.medical_specialtyAortic Valve Insufficiencymedicine.disease_causeInternal medicineStreptococcal InfectionsmedicineEndocarditisHumansRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studyWound Healingbusiness.industryFollow up studiesClinical courseMitral Valve InsufficiencyEndocarditis BacterialMiddle AgedStaphylococcal Infectionsmedicine.diseaseAbscessSurgeryTransesophageal approachStaphylococcus aureusEchocardiographyInfective endocarditisAortic ValveCardiologyMitral ValveFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessVegetation (pathology)Follow-Up StudiesJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Ocular Penetration of Topically Applied Norfloxacin 0.3% in the Rabbits and in Humans

1992

The kinetics of topically applied norfloxacin 0.3 percent were studied in rabbit and man. All measurements were performed by high-pressure liquid chromatography. Norfloxacin concentrations were investigated five to 120 minutes in rabbit ocular tissues after instillation of a single drop. In normal eyes, after 30 minutes, mean +/- SEM levels were 14.3 +/- 3.7 micrograms/g in cornea, 3.3 +/- 0.7 micrograms/g in conjunctiva, 0.2 +/- 0.1 microgram/g in aqueous humor. After removal of the corneal epithelium concentrations were as follows: 84.2 +/- 15.8 micrograms/g, 7.3 +/- 2.3 micrograms/g, 8.6 +/- 1.9 micrograms/g respectively. Penetration in posterior ocular tissues were rather poor. In human…

AdultMalemedicine.medical_specialtyConjunctivaAdolescentgenetic structures[SDV]Life Sciences [q-bio]EyeCorneaPharmacokineticsCorneaOphthalmologymedicineAnimalsHumansTissue DistributionPharmacology (medical)Chromatography High Pressure LiquidNorfloxacinAgedAntibacterial agentCorneal epitheliumAged 80 and overPharmacologyLagomorphabiologybusiness.industryPenetration (firestop)Middle Agedbiology.organism_classificationeye diseasesSurgeryOphthalmologymedicine.anatomical_structureFemaleRabbitssense organsOphthalmic SolutionsbusinessKeratoplasty PenetratingNorfloxacinmedicine.drugJournal of Ocular Pharmacology and Therapeutics
researchProduct

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

2009

AIM: To estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO. METHODS: Our survey included 115 patients fulfilling the Rome II criteria for diagnosis of irritable bowel syndrome (IBS); a total of 97 patients accepted to perform a breath test with lactulose (BTLact), and those who had a positive test, received Rifaximin (Normix®, Alfa Wassermann) 1200 mg/d for 7 d; 3 wk after the end of treatment, the BTLact was repeated. RESULTS: Based on the BTLact results, SIBO was present in about 5…

AdultMalemedicine.medical_specialtyConstipationGastroenterologyRifaximinIrritable Bowel SyndromeLactulosechemistry.chemical_compoundAnti-Infective AgentsGastrointestinal AgentsInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansSicilyIrritable bowel syndromeBreath testSettore MED/12 - GastroenterologiaGastrointestinal agentmedicine.diagnostic_testbusiness.industrydigestive oral and skin physiologyGastroenterologyBacterial InfectionsGeneral Medicinemedicine.diseaseRifamycinsLactuloseRifaximinBrief ArticlesBreath TestschemistryEtiologyFemalemedicine.symptombusinessSIBO rifaximinemedicine.drugWorld Journal of Gastroenterology
researchProduct

Effects of intraocular cefotaxime on the human corneal endothelium

2001

Abstract Purpose To ascertain whether 0.4 mL of cefotaxime 0.25% applied intracamerally causes toxic alteration of the human corneal endothelium. Methods In this prospective randomized masked study, 66 patients had cataract extraction using phacoemulsification, a frown incision, and implantation of a poly(methyl methacrylate) intraocular lens. This was followed by intraocular injection of 0.4 mL of cefotaxime 0.25% or balanced salt solution (BSS®). Contact specular microscopy and photography were performed preoperatively and 1 to 4 days and 3 months postoperatively. Results In the cefotaxime group, the mean endothelial cell count was 2729 cells/mm 2 ± 474 (SD) preoperatively, 2520 ± 462 cel…

AdultMalemedicine.medical_specialtyCorneal endotheliumCefotaximeAnterior Chambermedicine.medical_treatmentCell CountIntraocular lensBalanced salt solutionCefotaximeDouble-Blind MethodLens Implantation IntraocularCorneaOphthalmologymedicineHumansProspective StudiesAgedCell SizeAntibacterial agentAged 80 and overEndophthalmitisPhacoemulsificationbusiness.industryEndothelium CornealPhacoemulsificationMiddle AgedSensory SystemsCephalosporinsEndothelial stem cellOphthalmologymedicine.anatomical_structureFemaleSurgerysense organsbusinessmedicine.drugJournal of Cataract and Refractive Surgery
researchProduct

Selection of optimal prophylactic aminoglycoside dosage in cancer patients: population pharmacokinetic approaches.

1994

We report an alternative dose-finding approach for the selection of optimal prophylactic aminoglycoside dosage in specific (sub)populations of patients. Relative a priori utility of several intervals of gentamicin or tobramycin (AMG) peak and trough serum levels were assigned by a group of pharmacokinetics experts, assuming prophylactic administration for laryngectomy interventions. A group of 27 adult patients, with normal renal function, undergoing elective surgery for laryngeal problems and treated prophylactically with gentamicin (80 mg t.i.d.) or tobramycin (100 mg t.i.d.) was studied. Two blood samples (peak and trough) were drawn at steady-state for AMG assay. Three different methods…

AdultMalemedicine.medical_specialtyDosePremedicationPopulationUrologyPharmacologyPharmacokineticsmedicineTobramycinHumansPharmacology (medical)educationSelection (genetic algorithm)Antibacterial agentAgedPharmacologyAged 80 and overeducation.field_of_studybusiness.industryClindamycinAminoglycosideMiddle AgedAnti-Bacterial AgentsOtorhinolaryngologic NeoplasmsTobramycinGentamicinFemaleGentamicinsbusinessmedicine.drugJournal of clinical pharmacy and therapeutics
researchProduct

Intratympanic gentamicin treatment after endolymphatic sac surgery.

2005

Interval treatment with up to three intratympanic gentamicin injections once weekly effectively controlled vertigo while preserving hearing in patients with Ménière's disease and recurrent or resistant vertigo after saccotomy.Recurrent or resistant incapacitating vertigo may occur after endolymphatic sac surgery (saccotomy) in patients with Ménière's disease. In these patients, revision saccotomy, vestibular nerve section or labyrinthectomy are the established treatment options. We advocate a once-weekly application of intratympanic gentamicin (12 mg) as an effective alternative in this group of patients.Five patients (age range 39-65 years) with definite Ménière's disease according to the …

AdultMalemedicine.medical_specialtyEar MiddleEndolymphatic sacInjectionsPostoperative ComplicationsRecurrenceVertigootorhinolaryngologic diseasesmedicineHumansEndolymphatic HydropsEndolymphatic hydropsMeniere DiseaseAntibacterial agentAgedbiologymedicine.diagnostic_testbusiness.industryAminoglycosideElectronystagmographyAuditory ThresholdGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseSurgerymedicine.anatomical_structureOtorhinolaryngologyElectronystagmographyVertigoAudiometry Pure-ToneGentamicinFemaleEndolymphatic SacGentamicinsbusinessmedicine.drugMeniere's diseaseFollow-Up StudiesActa oto-laryngologica
researchProduct

Functional signs in patients consulting for presumed Lyme borreliosis

2019

Little is known about the functional symptoms associated with Lyme borreliosis (LB) in Europe. We aimed to assess functional symptoms associated with presumed LB and to compare patients with and without confirmed LB.We performed a retrospective monocenter study. Patients consulting for presumed LB were included.Between November 2015 and June 2018, 355patients were included (mean age: 51years, 52% of women) of which 48had LB: erythema migrans (42%), early disseminated LB (50%; 35% of neuroborreliosis cases), and late disseminated LB (8%). The most frequently reported functional symptoms were neuropathic pain (23%), arthralgia (23%), and asthenia (17%). Other functional symptoms were rare (≤1…

AdultMalemedicine.medical_specialtyFunctional symptomsDiagnosis Differential03 medical and health sciencesLyme diseasemedicineHumansLyme NeuroborreliosisLyme diseaseIn patientSerologic TestsReferral and ConsultationAgedRetrospective StudiesLyme borreliosis0303 health sciences030306 microbiologyLyme borreliosisbusiness.industryMean ageMiddle Agedmedicine.diseaseDermatology3. Good healthAnti-Bacterial Agents[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyInfectious DiseasesTreatment OutcomeBorrelia burgdorferiNeuropathic painErythema migransErythema Chronicum MigransFemaleFranceSymptom AssessmentbusinessNeuroborreliosis[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct